{"id":172,"date":"2026-07-29T05:17:11","date_gmt":"2026-07-29T05:17:11","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/dental-partnership-exit-strategies\/"},"modified":"2026-07-29T05:17:11","modified_gmt":"2026-07-29T05:17:11","slug":"dental-partnership-exit-strategies","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/dental-partnership-exit-strategies\/","title":{"rendered":"Dental Partnership Exit Strategies: A Guide for Dentists"},"content":{"rendered":"<h2 id=\"key-takeaways\">Key Takeaways<\/h2>\n<ul>\n<li>A dental partnership exit strategy is a planned process that transfers ownership while preserving practice value, patient continuity, and staff stability through clear valuation, buy-sell triggers, and tax treatment.<\/li>\n<li>Practice owners can choose among internal buyouts, associate buy-ins, or DSO affiliation, and each path uses different valuation methods, timelines, and post-transition work expectations.<\/li>\n<li>Well-drafted partnership agreements with updated valuations, clear triggers, and non-compete clauses can reduce disputes and IRS tax exposure during an exit.<\/li>\n<li>A structured, competitive sales process can increase total transaction value, and DSO buyers can sometimes offer 40\u201380% higher valuations than private buyers.<\/li>\n<li>McLerran &amp; Associates focuses on sell-side guidance for every stage of a partnership exit; <a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">explore your options in a free, confidential discovery call<\/a>.<\/li>\n<\/ul>\n<h2>Clarify Your Dental Partnership Exit Options<\/h2>\n<p>The first step in any partnership exit is seeing the full landscape of realistic paths. Many practice owners have more options than they expect, and the right choice can depend on practice size, profitability, personal goals, and the local buyer market.<\/p>\n<h3>Comparing Internal Partner Buyouts and Associate Buy-Ins<\/h3>\n<p>An internal partner buyout occurs when one partner purchases the other\u2019s ownership interest under a pre-existing buy-sell agreement. An associate buy-in works in the opposite direction, as a producing associate purchases a partial ownership stake, often through a phased transaction over several years. <a href=\"https:\/\/dentalpracticeloanguide.com\/learn\/dental-practice-transition\/\" target=\"_blank\" rel=\"noindex nofollow\">The typical timeline to close for associate buy-in or partnership vest-out dental deals is 2\u20134 months for the transaction phase or 9\u201318 months end-to-end for full transition<\/a>, and this period usually includes valuation at each tranche, capital contribution mechanics, and detailed agreements for profit-sharing and decision-making.<\/p>\n<p>For private doctor-to-doctor transactions, valuation commonly relies on a percentage of annual collections or a multiple of seller\u2019s discretionary earnings (SDE, meaning net income plus owner compensation, discretionary expenses, non-recurring items, and depreciation). Doctor-to-doctor (solo buyer) valuation is typically 60\u201385% of annual collections, and associate buy-ins are often structured with seller financing. These figures can vary widely based on practice-specific factors, so owners can treat any range as a starting point for a formal valuation rather than a promise.<\/p>\n<h3>Essential Clauses in Dental Partnership Agreements<\/h3>\n<p>A well-drafted partnership agreement can support a clean exit. <a href=\"https:\/\/privatebank.jpmorgan.com\/nam\/en\/insights\/markets-and-investing\/ideas-and-insights\/why-your-business-needs-a-buy-sell-agreement-and-how-to-make-one\" target=\"_blank\" rel=\"noindex nofollow\">The most important provisions address what triggers a transaction, how ownership is valued, how the purchase is structured, and how it is funded.<\/a> Common triggering events include death, permanent disability, retirement, voluntary departure, bankruptcy, and divorce.<\/p>\n<p>Valuation methodology can be one of the main sources of disputes. <a href=\"https:\/\/captyx.com\/buy-sell-agreement-valuation-a-small-business-guide\" target=\"_blank\" rel=\"noindex nofollow\">Industry best practices recommend updating buy-sell agreement valuations at least annually or immediately after major business changes<\/a>, such as significant earnings shifts or the addition of a new partner. A fixed price that is never updated can become dangerously stale, and <a href=\"https:\/\/captyx.com\/buy-sell-agreement-valuation-a-small-business-guide\" target=\"_blank\" rel=\"noindex nofollow\">an outdated fixed-price valuation can trigger IRS Section 2703 tax exposure<\/a> if the IRS decides the contract price no longer reflects fair market value.<\/p>\n<p>Other critical clauses can include non-compete and non-solicitation provisions, overhead allocation formulas, dispute resolution mechanisms, and clear definitions of who can acquire ownership interests. Since most state laws prohibit non-dentists from directly owning dental practices, while many permit indirect participation through management structures and rules vary by state, agreements usually need to restrict transfers to licensed practitioners.<\/p>\n<h3>How DSO Sales Shape Partnership Exit Choices<\/h3>\n<p>When a practice grows beyond what a single private buyer can finance, a DSO (Dental Service Organization) affiliation can become a practical and sometimes more lucrative exit path. <a href=\"https:\/\/privatepracticeresearch.org\/reports\/how-dental-practices-are-valued-2026\" target=\"_blank\" rel=\"noindex nofollow\">The same dental practice can receive valuations differing by 40%\u201380% depending on buyer type<\/a>, and institutional DSO offers can create a structural premium over private-buyer collections-based pricing. DSO buyers often apply EBITDA (earnings before interest, taxes, depreciation, and amortization, a standardized measure of operating profitability) multiples instead of collections percentages, which can materially change the headline number.<\/p>\n<p>DSO deals, however, often involve more complex structures. Typical DSO acquisitions can include 60%\u201380% cash at close, 15%\u201340% rollover equity into the DSO\u2019s parent company, and a 1\u20133 year earnout tied to post-close EBITDA maintenance. Up to 40% of the total deal value can be paid in equity rather than cash, so the seller effectively becomes an investor in the DSO, which usually calls for its own due diligence.<\/p>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Discuss which path, private buyer or DSO, aligns with your practice size, goals, and timeline in a free, confidential discovery call with McLerran &amp; Associates<\/a>.<\/p>\n<h2>Create Competition Among Qualified Buyers<\/h2>\n<p>The number of buyers at the table can be one of the main levers a selling dentist controls. A practice owner may sell once in a lifetime, while a DSO negotiates deals every week. Without competitive tension, the buyer can set the terms, and the seller has limited insight into whether the offer reflects the broader market.<\/p>\n<p>Before that competition can work in your favor, you need a clear sense of what buyers are actually bidding on, which is why valuation work usually comes first.<\/p>\n<h2>Valuation Methodology for Dental Partnership Interests<\/h2>\n<p>Controlling the narrative around your EBITDA starts with a defensible, diligence-grade valuation, not a quick estimate. McLerran &amp; Associates builds each engagement on a CPA-led EBITDA analysis that documents every add-back, meaning legitimate adjustments to reported income such as above-market owner compensation, personal expenses run through the practice, and non-recurring costs, before the practice goes to market. Because this work happens up front, McLerran\u2019s valuations can hold under buyer scrutiny and deals are less likely to be re-traded during due diligence.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<p>The valuation methodology applied can depend on buyer type and practice scale. For doctor-to-doctor transactions, value is often expressed as a percentage of collections or a multiple of net cash flow, while DSO and private equity buyers tend to apply EBITDA multiples. This difference can mean that the same practice receives materially different offers depending on who is bidding. A competitive sales process can amplify that spread by surfacing the strongest valuation from each buyer category.<\/p>\n<p>Owner dependence, meaning the degree to which the selling doctor personally produces the practice\u2019s revenue, can act as a major discount factor across methodologies. Practices with durable associate coverage often achieve higher multiples than comparable solo-doctor practices. Practices where the selling doctor produces 90% or more of clinical revenue can face meaningful valuation haircuts regardless of the approach used.<\/p>\n<p>McLerran\u2019s structured, auction-style process typically runs 45\u201360 days and can generate around 10 offers from vetted, pre-qualified buyers, which creates the competitive tension that can move price and terms toward the seller\u2019s interests. Poorly run or undercapitalized buyers are screened out before they reach the table. For owners weighing both paths, McLerran prepares a side-by-side valuation that quantifies the practice\u2019s worth in both the private-buyer and DSO markets, so the decision can rest on complete information.<\/p>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Find out what your practice may be worth, and how a competitive process could affect your outcome, by scheduling a confidential valuation consultation<\/a>.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<h2>Match Your Exit Path to Your Practice and Lifestyle<\/h2>\n<p>Sale price matters, and so does fit. The highest bidder may not be the right buyer, and a misaligned partnership can create years of friction for staff and patients.<\/p>\n<h3>Phased Retirement and Patient Continuity Planning<\/h3>\n<p>The way a seller exits clinically can have a direct impact on practice value. A selling dentist who stays on after closing can often help retain most patients, while exiting at close can increase the risk of patient attrition. Patient retention in the first 12 months after closing can drive much of the acquisition outcome, which is why buyers, especially DSOs, often request multi-year employment commitments.<\/p>\n<p>For owners pursuing a doctor-to-doctor walk-away sale, the work-back period is typically 4\u20138 weeks. For partnership vest-out structures, where a seller transfers roughly 50% now to a future partner who purchases the remainder over time, the transition usually unfolds more gradually and can span several years. This structure can preserve continuity while allowing the seller to reduce clinical hours step by step.<\/p>\n<p>The table below summarizes how valuation approach, timeline, and post-close work expectations can differ across three primary exit paths, which can help you see which structure may align with your financial goals and preferred level of ongoing involvement.<\/p>\n<table>\n<thead>\n<tr>\n<th>Path<\/th>\n<th>Valuation Approach<\/th>\n<th>Typical Timeline to Close<\/th>\n<th>Post-Deal Work Expectation<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Doctor-to-Doctor (Walk-Away)<\/td>\n<td>60\u201385% of annual collections<\/td>\n<td>60\u2013120 days<\/td>\n<td>30\u201390 day transition<\/td>\n<\/tr>\n<tr>\n<td>Associate Buy-In \/ Partnership Vest-Out<\/td>\n<td>multiple of SDE with seller financing<\/td>\n<td><a href=\"https:\/\/dentalpracticeloanguide.com\/learn\/dental-practice-transition\/\" target=\"_blank\" rel=\"noindex nofollow\">2\u20134 months for the transaction phase or 9\u201318 months end-to-end<\/a><\/td>\n<td>Ongoing clinical role during vesting period<\/td>\n<\/tr>\n<tr>\n<td>DSO Affiliation (Add-On)<\/td>\n<td>5\u00d7\u20138\u00d7 adjusted EBITDA depending on practice scale<\/td>\n<td>3\u20136 months<\/td>\n<td>typically a 3\u20135 year employment commitment<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Compare these paths side by side against your specific practice profile and personal goals in a no-obligation discovery call<\/a>.<\/p>\n<h2>Structure Your Deal to Maximize Net Proceeds<\/h2>\n<p>A strong valuation and a competitive process can be helpful, yet they may not be sufficient on their own. Maximizing the outcome can also involve understanding how the deal is structured, how proceeds are taxed, and how to protect the value that has been negotiated through closing.<\/p>\n<p>Tax treatment can vary significantly by deal structure. In an asset sale, the structure used in the vast majority of dental practice transactions, the seller can face different tax treatment across asset categories: goodwill and patient records are generally taxed at long-term capital gains rates (approximately 20% federal), while equipment depreciation recapture and restrictive covenant payments are taxed as ordinary income at rates up to 37%. Because goodwill often represents the largest portion of a dental practice\u2019s value, sellers can benefit from maximizing the allocation to goodwill in the purchase price agreement, although this remains a negotiated outcome with real tax consequences for both sides. A qualified CPA or tax advisor can provide guidance before any allocation is finalized.<\/p>\n<p>DSO deals can introduce additional complexity. Rollover equity, meaning the portion of the deal paid in DSO stock rather than cash, can be held at the joint-venture level, with ongoing distributions and a higher floor but lower ceiling, or at the holding-company level, with no distributions but potential for significant upside if the DSO recapitalizes. Earnout payments in a dental practice sale are treated as capital gains if classified as deferred purchase price, but may be recharacterized as ordinary compensation income if the seller continues providing services post-closing or if non-compete provisions are present. Careful earnout structuring, including pro-rata provisions so a near-miss on an EBITDA target still pays most of the earnout, is a core part of McLerran\u2019s LOI negotiation work.<\/p>\n<p>McLerran &amp; Associates operates exclusively on the sell side, so the firm\u2019s incentives align with the practice owner rather than the buyer. With roughly 2,000 successful practice sales, approximately $2 billion in closed transaction volume, and more than 10,000 practices evaluated, the firm reports a transaction rate of approximately 85%\u201390% among its clients, compared to an industry norm closer to 35%\u201340%.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What triggers a dental partnership exit, and how should those triggers be defined in advance?<\/h3>\n<p>Common triggering events in dental partnership agreements include death, permanent disability, retirement, voluntary departure, professional license revocation, personal bankruptcy, and divorce. Each trigger can be defined with specificity in the buy-sell agreement, including the valuation date, payment timeline, and funding mechanism for each scenario. A disability trigger, for example, may call for a later valuation date once the extent of incapacity is clear, while a death trigger typically requires immediate funding through life insurance. Agreements that leave these terms vague or unaddressed can become a frequent source of partner disputes and litigation.<\/p>\n<h3>How is equity risk managed when a portion of a DSO deal is paid in stock?<\/h3>\n<p>When a portion of a DSO deal is paid in equity rather than cash, the seller effectively becomes an investor in the DSO, and that investment can warrant careful scrutiny. Key questions can include whether the DSO\u2019s existing locations are profitable, whether revenue is still growing across its portfolio, whether the management team has relevant experience, and whether the private equity firm backing the DSO has a track record of successful exits. McLerran evaluates buyers as investments, steering clients away from undercapitalized or poorly run DSOs and toward well-backed partners with a history of satisfied sellers. The equity structure, joint-venture level versus holding-company level, also determines whether the seller receives ongoing distributions and how any upside is realized at a future recapitalization.<\/p>\n<h3>How does McLerran\u2019s valuation process differ from a free valuation?<\/h3>\n<p>A free valuation often serves as a lead-generation tool and can be a quick estimate that has not been stress-tested against the practice\u2019s actual financials. When a buyer\u2019s quality-of-earnings team reviews the numbers during due diligence, a weak valuation can be re-traded, meaning the agreed price comes down and the seller has limited leverage to resist. McLerran\u2019s CPA-led EBITDA analysis is diligence-grade work completed before the practice goes to market. Every add-back is documented and defensible. Because this homework is done up front, the numbers can hold when buyers review them, and the agreed value has a better chance of matching the value at closing. In one case, a free valuation placed a practice at $2.5 million, while McLerran valued it at $4.5 million and it sold for $5.25 million after a competitive process.<\/p>\n<h3>How are staff and patients protected during a partnership exit?<\/h3>\n<p>Patient and staff protection is built into McLerran\u2019s process at multiple stages. On the buyer-selection side, the firm weighs fit alongside price, identifying buyers whose clinical philosophy, operational model, and support infrastructure align with what the selling doctor wants for the practice after departure. On the process side, McLerran serves as a buffer between seller and buyer throughout the transaction, which can protect goodwill and staff relationships from the friction that direct negotiations sometimes create. After closing, a structured transition presence, whether a short work-back in a doctor-to-doctor deal or a multi-year clinical role in a DSO affiliation, can be one of the most reliable drivers of patient retention and practice continuity.<\/p>\n<h3>When is the right time to engage a sell-side advisor?<\/h3>\n<p>Many owners find that engaging earlier than expected can be helpful. The preparation phase, which can include reducing owner dependence, building associate depth, cleaning up financials, and confirming that the practice\u2019s systems are scalable, can take 12\u201318 months and can have a direct impact on valuation. Owners who engage McLerran before they are ready to sell receive a comprehensive valuation at the outset and a free update one year later, so they can enter the market with more complete information and less pressure. Given that a significant portion of the dental workforce is approaching retirement age, and that expiring tax provisions in 2026 are creating urgency for some mid-career sellers, the cost of waiting may not be neutral. McLerran will also tell a client candidly if the timing does not look right and will be prepared to assist when it improves.<\/p>\n<h2>Conclusion<\/h2>\n<p>A dental partnership exit functions as a structured journey through four connected decisions: understanding the available paths, creating competition among qualified buyers, finding the right fit for the practice\u2019s legacy, and structuring the deal to support the after-tax outcome. Each step can build on the last, and the difference between a well-run process and an unrepresented one can sometimes be measured in millions of dollars and years of post-deal regret.<\/p>\n<p>McLerran &amp; Associates has guided practice owners through approximately 2,000 successful transitions, closing roughly $2 billion in transaction volume across both doctor-to-doctor and DSO pathways in roughly equal measure. That dual-path capability is relatively rare and can support a genuine side-by-side comparison instead of steering clients toward the lane the advisor knows best.<\/p>\n<p>The largest financial decision of a dental career can benefit from a sell-side advisor and advocate who helps control the narrative around your EBITDA, creates real competition, and stays in your corner from first conversation through closing. <a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Arrange a free, confidential discovery call with McLerran &amp; Associates<\/a> to explore what your practice may be worth and what the right exit could look like for you.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Explore buyouts, associate buy-ins, and DSO sales for your dental exit. McLerran provides expert sell-side guidance \u2014 get a free consultation today.<\/p>\n","protected":false},"author":1,"featured_media":171,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-172","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=172"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/172\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/171"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}